Investor Overview
News
- Kindred Biosciences Announces Plan to Strengthen its Strategic PositionJune 8, 2020 4:02 PM EDT
- Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with VaxartMay 20, 2020 7:58 AM EDT
- Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws ConferenceMay 13, 2020 8:30 AM EDT
Events
- Wednesday, May 27, 2020 12:05 PM EDT
- Thursday, May 7, 2020 4:30 PM EDT
- Monday, March 16, 2020 4:30 PM EDT
|
||||||||||||||||
KindredBio proudly supports
Rabies Free Africa
Investor Overview
KindredBio is focused on bringing innovative biologics and technologies to veterinary medicine to address unmet clinical needs and provide benefits to pets.
Stock Information
News
Kindred Biosciences Announces Plan to Strengthen its Strategic Position
June 8, 2020
SAN FRANCISCO , June 8, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences Announces COVID-19 Vaccine Manufacturing Agreement with Vaxart
May 20, 2020
SAN FRANCISCO , May 20, 2020 /PRNewswire/ -- Kindred Biosciences, Inc. (NASDAQ: K...
Kindred Biosciences to Present at Stifel 2020 Virtual Jaws & Paws Conference
May 13, 2020
SAN FRANCISCO , May 13, 2020 /PRNewswire/ -- Kindred Biosciences , Inc. (NASDAQ: ...